What does CUSIP 74006W207 represent in this 13F holders report?

CUSIP 74006W207 is the security identifier for PRAX - Praxis Precision Medicines, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PRAX - Praxis Precision Medicines, Inc. - Common Stock in Q4 2023?

57 institutional investors reported PRAX - Praxis Precision Medicines, Inc. - Common Stock for Q4 2023. Use the holders table for investor-level position and value details.

Praxis Precision Medicines, Inc. - Common Stock (PRAX)

CUSIP: 74006W207

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock
Shares outstanding: 27,884,538
Total 13F shares: 7,555,380
Share change: +7,555,380
Total reported value: $168,332,336
Put/Call ratio: 2.8%
Price per share: $22.28
Number of holders: 57
Value change: +$168,332,336
Number of buys: 57

Quarterly Holders Quick Answers

What is CUSIP 74006W207?
CUSIP 74006W207 identifies PRAX - Praxis Precision Medicines, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024

Recent filing periods for CUSIP 74006W207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PRAX - Praxis Precision Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Clarus Lifesciences III, L.P.	3/4/5	10%+ Owner	— class O/S missing	4,894,109	$123,282,606	—	12 May 2021	3/4/5
Point72 Asset Management, L.P.	13F	Company	— class O/S missing	10,383,780	$17,756,264	—	30 Sep 2023	13F
Cormorant Asset Management, LP	13F	Company	— class O/S missing	9,500,000	$16,245,000	—	30 Sep 2023	13F
Verition Fund Management LLC	13F	Company	— class O/S missing	9,059,839	$15,492,325	—	30 Sep 2023	13F
PFM Health Sciences, LP	13F	Company	— class O/S missing	8,919,997	$15,253,195	—	30 Sep 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	— class O/S missing	8,780,000	$15,013,800	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	5,564,114	$9,514,635	—	30 Sep 2023	13F
VR Adviser, LLC	13F	Company	— class O/S missing	5,304,410	$9,070,541	—	30 Sep 2023	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	— class O/S missing	5,200,000	$8,892,000	—	30 Sep 2023	13F
Velan Capital Investment Management LP	13F	Company	— class O/S missing	5,185,000	$8,866,350	—	30 Sep 2023	13F
Tri Locum Partners LP	13F	Company	— class O/S missing	4,855,783	$8,303,389	—	30 Sep 2023	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	— class O/S missing	4,850,317	$8,294,042	—	30 Sep 2023	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	— class O/S missing	4,485,000	$7,669,350	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	4,171,107	$7,132,593	—	30 Sep 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	4,117,920	$7,041,643	—	30 Sep 2023	13F
Ikarian Capital, LLC	13F	Company	— class O/S missing	2,250,000	$3,847,501	—	30 Sep 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	— class O/S missing	1,879,915	$3,214,655	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	1,874,843	$3,205,981	—	30 Sep 2023	13F
CIBC Asset Management Inc	13F	Company	— class O/S missing	1,825,910	$3,122,306	—	30 Sep 2023	13F
Vida Ventures Advisors, LLC	13F	Company	— class O/S missing	1,469,665	$2,513,127	—	30 Sep 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	— class O/S missing	1,434,474	$2,451,000	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	1,298,186	$2,220,470	—	30 Sep 2023	13F
Soleus Capital Management, L.P.	13F	Company	— class O/S missing	1,150,000	$1,966,500	—	30 Sep 2023	13F
Ally Bridge Group (NY) LLC	13F	Company	— class O/S missing	1,056,370	$1,806,393	—	30 Sep 2023	13F
Blackstone Inc.	13F	Company	— class O/S missing	1,054,109	$1,802,526	—	30 Sep 2023	13F
72 Investment Holdings, LLC	13F	Company	— class O/S missing	988,995	$1,691,181	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	977,000	$1,671,000	—	30 Sep 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	— class O/S missing	683,379	$1,168,578	—	30 Sep 2023	13F
Altium Capital Management LLC	13F	Company	— class O/S missing	650,000	$1,111,500	—	30 Sep 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	— class O/S missing	632,543	$1,081,648	—	30 Sep 2023	13F
MARSHALL WACE, LLP	13F	Company	— class O/S missing	626,669	$1,071,604	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	618,540	$1,057,703	—	30 Sep 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	— class O/S missing	583,544	$997,860	—	30 Sep 2023	13F
Nicole Sweeny	3/4/5	Chief Commercial Officer	— class O/S missing	38,619	$972,813	—	12 Feb 2023	3/4/5
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	— class O/S missing	453,150	$774,887	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	296,009	$506,175	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	— class O/S missing	290,213	$496,264	—	30 Sep 2023	13F
J. Goldman & Co LP	13F	Company	— class O/S missing	270,000	$461,700	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	206,770	$353,577	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	— class O/S missing	206,555	$353,209	—	30 Sep 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	201,700	$344,907	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	182,499	$312,073	—	30 Sep 2023	13F
Atom Investors LP	13F	Company	— class O/S missing	102,779	$175,752	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	92,613	$158,368	—	30 Sep 2023	13F
CITIGROUP INC	13F	Company	— class O/S missing	83,115	$142,127	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	— class O/S missing	75,077	$128,382	—	30 Sep 2023	13F
PEAK6 Investments LLC	13F	Company	— class O/S missing	64,468	$110,240	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	— class O/S missing	56,900	$97,299	—	30 Sep 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	— class O/S missing	56,130	$95,982	—	30 Sep 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	— class O/S missing	34,652	$59,255	—	30 Sep 2023	13F

Institutional Holders of Praxis Precision Medicines, Inc. - Common Stock (PRAX) as of Q4 2023

As of 31 Dec 2023, Praxis Precision Medicines, Inc. - Common Stock (PRAX) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,555,380 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Verition Fund Management LLC, Point72 Asset Management, L.P., PFM Health Sciences, LP, Cormorant Asset Management, LP, VANGUARD GROUP INC, VR Adviser, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Velan Capital Investment Management LP, and ACUTA CAPITAL PARTNERS, LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders

247

Q4 2023 holders

Holder diff

-190

Investor	Q4 2025 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.